Legend Biotech Corp. (LEGN): Rasio utang jangka dawa marang modal

This daily price action for Legend Biotech (LEGN) on the GURU.Markets platform demonstrates metrics where the value is 0.09. The success of this biotech business relies on clinical trial results, regulatory verdicts, and insurance reimbursement terms. Meanwhile, Legend Biotech (LEGN) is implementing ESG principles by reducing chemical waste and strictly adhering to sanitary regulations for hazardous waste disposal to ensure maximum biosafety.

This indicator compares the volume of liabilities with a maturity of over one year against the amount of equity, measuring the degree of debt load on the business's financial stability. A decrease in this parameter confirms deleveraging, which is critical for Legend Biotech (LEGN) when splitting cell therapy costs with partners, and is clearly reflected in the ratio of long-term loans to equity.